Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

REGULUS THERAPEUTICS INC.

(RGLS)
  Report
Delayed Nasdaq  -  03:59 2022-12-02 pm EST
1.720 USD   +1.78%
11/29Regulus Therapeutics Inc. Announces Executive Changes
CI
11/14REGULUS THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
11/10Regulus : Q3 Earnings Snapshot
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart REGULUS THERAPEUTICS INC.
Upcoming events on REGULUS THERAPEUTICS INC.
03/08/23 FY 2022 Earnings Release (Projected)
05/11/23 Q1 2023 Earnings Release (Projected)
08/10/23 Interim 2023 Earnings Release (Projected)
11/09/23 Q3 2023 Earnings Release (Projected)
Past events on REGULUS THERAPEUTICS INC.
11/10/22 | 05:00pm Q3 2022 Earnings Call
11/10/22 | 04:05pm Q3 2022 Earnings Release
11/03/22 | 09:00am American society of nephrology kidney week conference - abstract number: 3768400
09/12/22 | 02:30pm H.C. Wainwright Global Investment Conference
09/07/22 Wells Fargo Healthcare Conference
08/11/22 | 05:00pm Interim 2022 Earnings Call
08/11/22 | 04:10pm Interim 2022 Earnings Release
06/29/22 REVERSE SPLIT: 1 of 10
06/09/22 | 12:00pm Annual General Meeting
05/24/22 | 07:00am H.C. Wainwright Global Life Sciences Investment Conference
Past dividends on REGULUS THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
0,07
0,11
-32%
0,07
3,57
-98%
6,83
6,86
-0,38%
10,0
5,02
99%


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-70,1
-70,8
0,88%
-46,8
-43,0
-8,7%
-16,8
-17,2
2,2%
-14,2
-19,2
26%
-27,8
-27,4
-1,4%
 
-28,8
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-72,1
-72,3
0,25%
-48,6
-44,8
-8,6%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-29,1
 
Net income
M $
Released
Forecast
Spread
-71,9
-72,2
0,37%
-48,7
-44,8
-8,7%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-29,1
 
EPS
$
Released
Forecast
Spread
-115
-120
4,2%
-55,9
-33,3
-68%
-10,8
-11,0
1,8%
-4,50
-6,60
32%
-3,20
-3,27
2,0%
 
-1,83
 
Announcement Date03/07/201803/18/201903/12/202003/09/202103/10/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread

0,00
 


 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-8,42
-6,50
-30%
-6,96
-6,57
-5,9%
-6,57
-7,21
8,8%
-7,18
-7,05
-1,8%
-7,56
-7,35
-2,9%
 
-7,58
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
-7,55
-7,39
-2,1%
 
-7,60
 
Net income
M $
Released
Forecast
Spread
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
-7,55
-7,39
-2,1%
 
-7,62
 
EPS
$
Released
Forecast
Spread
-1,00
-0,78
-29%
-0,70
-0,67
-5,0%
-0,50
-0,53
6,2%
-0,50
-0,49
-3,1%
-0,50
-0,49
-2,0%
 
-0,51
 
Announcement Date11/10/202103/10/202205/12/202208/11/202211/10/2022-
Previous year Next Year
Upcoming sector events for REGULUS THERAPEUTICS INC.
More events
Past sector events for REGULUS THERAPEUTICS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise